Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Context-specific roles for paracrine IL-6 in lymphomagenesis.

Gilbert LA, Hemann MT.

Genes Dev. 2012 Aug 1;26(15):1758-68. doi: 10.1101/gad.197590.112.

2.
3.

Promotion of Expansion and Differentiation of Hematopoietic Stem Cells by Interleukin-27 into Myeloid Progenitors to Control Infection in Emergency Myelopoiesis.

Furusawa J, Mizoguchi I, Chiba Y, Hisada M, Kobayashi F, Yoshida H, Nakae S, Tsuchida A, Matsumoto T, Ema H, Mizuguchi J, Yoshimoto T.

PLoS Pathog. 2016 Mar 18;12(3):e1005507. doi: 10.1371/journal.ppat.1005507. eCollection 2016 Mar.

7.

Blood stem cell fate regulation by Delta-1-mediated rewiring of IL-6 paracrine signaling.

Csaszar E, Wang W, Usenko T, Qiao W, Delaney C, Bernstein ID, Zandstra PW.

Blood. 2014 Jan 30;123(5):650-8. doi: 10.1182/blood-2013-08-520445. Epub 2013 Nov 15.

8.

Interleukin 6 mediated recruitment of mesenchymal stem cells to the hypoxic tumor milieu.

Rattigan Y, Hsu JM, Mishra PJ, Glod J, Banerjee D.

Exp Cell Res. 2010 Dec 10;316(20):3417-24. doi: 10.1016/j.yexcr.2010.07.002. Epub 2010 Jul 13.

PMID:
20633553
9.

The role of IL-4 in the generation of B lymphocytes in the bone marrow.

Simons A, Zharhary D.

J Immunol. 1989 Oct 15;143(8):2540-5.

PMID:
2794508
11.

Stage-specific roles for CXCR4 signaling in murine hematopoietic stem/progenitor cells in the process of bone marrow repopulation.

Lai CY, Yamazaki S, Okabe M, Suzuki S, Maeyama Y, Iimura Y, Onodera M, Kakuta S, Iwakura Y, Nojima M, Otsu M, Nakauchi H.

Stem Cells. 2014 Jul;32(7):1929-42. doi: 10.1002/stem.1670.

12.

Survival of B lineage leukemic cells: signals from the bone marrow microenvironment.

Gibson LF.

Leuk Lymphoma. 2002 Jan;43(1):19-27. Review.

PMID:
11908727
14.
16.

The role of interleukin-9 in lymphoma.

Lv X, Wang X.

Leuk Lymphoma. 2013 Jul;54(7):1367-72. doi: 10.3109/10428194.2012.745072. Epub 2012 Dec 5. Review.

PMID:
23127115
17.

Increased expression of PcG protein YY1 negatively regulates B cell development while allowing accumulation of myeloid cells and LT-HSC cells.

Pan X, Jones M, Jiang J, Zaprazna K, Yu D, Pear W, Maillard I, Atchison ML.

PLoS One. 2012;7(1):e30656. doi: 10.1371/journal.pone.0030656. Epub 2012 Jan 23.

18.

Pluripotent, cytokine-dependent, hematopoietic stem cells are immortalized by constitutive Notch1 signaling.

Varnum-Finney B, Xu L, Brashem-Stein C, Nourigat C, Flowers D, Bakkour S, Pear WS, Bernstein ID.

Nat Med. 2000 Nov;6(11):1278-81.

PMID:
11062542
19.

IGF signaling contributes to malignant transformation of hematopoietic progenitors by the MLL-AF9 oncoprotein.

Jenkins CR, Shevchuk OO, Giambra V, Lam SH, Carboni JM, Gottardis MM, Holzenberger M, Pollak M, Humphries RK, Weng AP.

Exp Hematol. 2012 Sep;40(9):715-723.e6. doi: 10.1016/j.exphem.2012.05.003. Epub 2012 May 18.

PMID:
22613471
20.

Mammalian target of rapamycin activation underlies HSC defects in autoimmune disease and inflammation in mice.

Chen C, Liu Y, Liu Y, Zheng P.

J Clin Invest. 2010 Nov;120(11):4091-101. doi: 10.1172/JCI43873. Epub 2010 Oct 25. Erratum in: J Clin Invest. 2010 Dec 1;120(12):4583.

Supplemental Content

Support Center